15 January - WHO departments of HIV/AIDS and Maternal, Newborn, Child and Adolescent Health convened an expert consultation in September 2014 to review the available data on HIV treatment issues among adolescents. There are over 2 million adolescents living with HIV, which became a leading cause of mortality for this age group. The report of the consultation includes full information on the meeting that focused on specific treatment needs of adolescents to inform the upcoming consolidated guidelines on antiretrovirals to be published in 2015.
There are over 3 million children living with HIV, but the vast majority have not been tested nor are they receiving the needed HIV treatment. The World Health Organization and global partners are organizing a series of events on 8-12 December 2014 in an effort to increase access to testing and treatment for infants and children in need.
1 December 2014 – WHO released a new supplement to the 2013 ARV guidelines, which addresses two important and neglected areas of the HIV response. These include new recommendations on post-exposure prophylaxis (PEP) enabling emergency prevention for those in need, with a single 28-day course of antiretrovirals. New recommendations on affordable cotrimoxazole prophylaxis for those living with HIV, and also burdened with malaria and bacterial infections, are included in the new supplement.
11.7 million At the end of 2013, 11.7 million people had access to antiretroviral therapy in low- and middle-income countries.Fact sheet on HIV/AIDS
35 millionAt the end of 2013, 35 million people were living with HIV.Online Q&A about HIV/AIDS
28 million Over 28 million people are eligible for antiretroviral therapy, under WHO 2013 consolidated ARV guidelines.10 facts on HIV
19 December 2014
17 November 2014